Home › Bayer expands patient assistance program for intrauterine devices
 

Keywords :   


Bayer expands patient assistance program for intrauterine devices

2015-02-23 17:11:52| Chemicals - Topix.net

Bayer HealthCare Pharmaceuticals Inc. today announced the expansion of its patient assistance program for intrauterine devices . The ARCH program will provide Skyla 13.5 mg and Mirena 52 mg to low-income women who meet eligibility criteria.

Tags: program assistance devices patient

Category:Chemicals

Latest from this category

All news
23.09Terrence Peters Joins Mule-Hide Products Co. as Territory Manager
21.09Weekly Recap: PPG, Axalta, AkzoNobel Top This Weeks Stories
20.09KANSAI HELIOS Further Expands as System Supplier in Italy
20.09New Acrylic Resin for Architectural Coatings Without Fluorosurfactants from EPS
20.09¦nie¿ka Publishes Results for 1H 2024
20.09Sheboygan Paint Company Appoints Fallon Phillip HR Director
20.09RadTech Europe (RTE) Sets Call for Papers
19.09Lubrizol Enhances Dispersant Production Capacity in North America
Chemicals »
23.09Tropical Storm John Update Statement
23.09Summary for Tropical Storm John (EP5/EP102024)
23.09Is the Budget's bite going to be rather less painful than its bark?
23.09Flushability Standard Introduced in China
23.09Union boss questions Amazon public contracts
23.09Texas Landowners Advocate for Major Changes to Oilfield Waste Disposal Procedures
23.09Long Islands Waste Future Uncertain as Landfill Closure Looms
23.09Mortgages at six times' income for first-time buyers
More »